Well Referenced

Tag: CR3

Effects of Orally Administered Yeast-Derived Beta-Glucans: A Review

This 2014 review examines the immunomodulatory effects of orally administered yeast-derived beta-glucans (Y-BG). Despite low systemic absorption, Y-BG interacts with intestinal immune cells via receptors like Dectin-1 and CR3, enhancing both innate and adaptive immunity. Clinical studies indicate benefits such as reduced upper respiratory tract infections in susceptible individuals, increased

Read More »
June 26, 2025 No Comments

Immune-modulatory Effects of Dietary Yeast Beta-1,3/1,6-D-glucan

This 2014 review evaluates the immunomodulatory properties of dietary yeast-derived β-1,3/1,6-D-glucan, focusing on its oral bioactivity and clinical relevance. Despite low systemic absorption, oral β-glucans interact with intestinal immune cells via receptors like Dectin-1, CR3, and TLRs, leading to enhanced innate and adaptive immune responses. Clinical trials with insoluble yeast

Read More »
June 26, 2025 No Comments

Effects of Beta-Glucans on the Immune System

This 2007 review article explores the immunomodulatory properties of β-glucans, naturally occurring polysaccharides found in the cell walls of fungi, bacteria, and cereals. The authors discuss how β-glucans enhance host immune defense by activating the complement system and enhancing the function of macrophages and natural killer (NK) cells. The article

Read More »
June 26, 2025 No Comments

The Effects of Beta-Glucan on Human Immune and Cancer Cells

This review explores the immunomodulatory and potential anti-cancer effects of β-glucans, complex polysaccharides found in the cell walls of fungi, bacteria, and cereals. β-glucans interact with immune receptors such as Dectin-1, complement receptor 3 (CR3), and Toll-like receptors (TLR-2/6), activating immune cells including macrophages, neutrophils, monocytes, natural killer (NK) cells,

Read More »
June 26, 2025 No Comments

The Application of Fungal β-Glucans for the Treatment of Colon Cancer

This 2013 review investigates the role of fungal β-glucans—bioactive polysaccharides derived mainly from mushrooms—in colon cancer therapy. β-glucans exert their antitumor effects primarily through immune system modulation, activating macrophages, dendritic cells, and natural killer cells via Dectin-1 and complement receptor 3 (CR3) pathways. These interactions promote cytokine secretion and enhance

Read More »
June 26, 2025 No Comments